Selank
The Russian Anxiolytic Peptide — Calm Without Sedation
Selank is a synthetic analogue of the endogenous peptide tuftsin, developed by the same Russian institute as Semax and approved in Russia as an anxiolytic medicine. It reduces anxiety, stabilizes mood, and enhances cognition under stress — without dependence, sedation, or cognitive impairment.
What Is Selank?
Selank (sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic analogue of tuftsin, an endogenous immunomodulatory peptide. It was developed at Russia's Institute of Molecular Genetics — the same research group that created Semax — and has been approved in Russia as an anxiolytic drug since the 1990s.
Unlike benzodiazepines, Selank produces anxiety relief without sedation, cognitive impairment, or addiction risk. It has been studied in Russian clinical trials for generalized anxiety disorder with consistently positive results and an excellent safety record.
Key distinction: Where Semax is stimulating and activating (focus, motivation), Selank is calming and stabilizing (anxiety relief, emotional balance). This makes them natural complements — the "Russian peptide stack."
How Selank Works
GABAergic Modulation
- • Modulates GABA-A receptor expression and sensitivity
- • Produces anxiolytic effect via GABAergic pathway
- • Unlike benzos: no receptor downregulation or tolerance
- • No physical dependence or withdrawal syndrome
Enkephalin Stabilization
- • Inhibits enkephalinase enzymes that break down enkephalins
- • Elevates endogenous opioid-like peptides (mood, wellbeing)
- • Reduces cortisol response to acute stress
- • Contributes to mood stability and emotional resilience
BDNF & Cognition
- • Increases BDNF and NGF similar to Semax
- • Cognitive enhancement under stressful conditions
- • Improves learning and memory consolidation
- • Reduces anxiety-induced cognitive impairment
Immune Modulation
- • Reduces IL-6 and TNF-α (pro-inflammatory cytokines)
- • Interest from MCAS and autoimmune communities
- • Tuftsin-derived — inherits immunomodulatory properties
- • May reduce neuroinflammation contributing to anxiety
Selank vs Benzodiazepines
| Property | Selank | Benzodiazepines |
|---|---|---|
| Anxiety Relief | Yes | Yes |
| Sedation | No | Yes (dose-dependent) |
| Cognitive Impairment | No (often enhances) | Yes (memory, attention) |
| Dependence Risk | None observed | High (physical dependence) |
| Withdrawal | None observed | Severe (seizure risk) |
| BDNF / Neuroplasticity | Increases BDNF | Reduces BDNF long-term |
Selank Dosing Protocol
Selank is administered intranasally only for CNS effects, identical to Semax. Standard concentration is 0.15% (1.5mg/mL). Each nasal spray typically delivers approximately 50-100mcg per nostril.
Cycle & Timing Notes
- • Cycle: 2-4 weeks on, 1-2 weeks off to assess baseline anxiety levels
- • Timing: Can be used morning, afternoon, or evening — does not cause stimulation
- • As needed: Some users take Selank situationally (before stressful events) rather than daily
- • With Semax: Semax in AM, Selank in PM or as needed for optimal balance
Side Effects & Safety Profile
Exceptional Safety Record
- • No dependence, addiction, or withdrawal reported
- • No sedation or impairment at standard doses
- • Russian clinical trials for GAD: positive results, minimal adverse events
- • No organ toxicity at standard doses
Minor Side Effects (Rare)
- • Mild fatigue at high doses (750mcg+)
- • Transient nasal irritation
- • Occasional mild drowsiness in sensitive individuals
- • No clinically significant adverse events in trials
Who Uses Selank
Anxiety Disorders
Generalized anxiety disorder (GAD), social anxiety, and performance anxiety without sedation or impairment.
Stress & Cognitive Performance
Users who need to remain sharp under high stress — reduces anxiety while maintaining or enhancing cognitive function.
PTSD & Trauma
Studied in Russian clinical settings for trauma-related anxiety; reduces hyperarousal without blunting emotional processing.
MCAS & Immune Conditions
IL-6 and TNF-α reduction attracts interest from mast cell and autoimmune communities for inflammatory anxiety overlap.
Overactive Mind at Night
Evening dosing helps quiet racing thoughts without next-day grogginess unlike hypnotics.
Social Anxiety
Selank specifically studied for social anxiety — reduces avoidance behavior while maintaining social cognition.
Frequently Asked Questions
How does Selank reduce anxiety without sedation?
Selank modulates the GABAergic system (the same pathway as benzodiazepines) but without causing receptor downregulation, sedation, or cognitive impairment. It also stabilizes enkephalins and reduces pro-inflammatory cytokines (IL-6, TNF-α) elevated in chronic anxiety and stress.
What is the recommended Selank dosage?
The standard dose is 250-500mcg per day administered intranasally (1-2 sprays per nostril, twice daily). Some users use up to 750mcg/day. Like Semax, Selank must be given intranasally to reach the CNS. Oral administration is degraded before reaching the brain.
Is Selank safe for long-term use?
Selank has no evidence of dependence or withdrawal in clinical studies, which sharply distinguishes it from benzodiazepines. Typical use is 2-4 weeks on, 1-2 weeks off to assess baseline anxiety. Russian clinical trials for GAD showed positive results with a strong safety profile.
Track Your Selank Protocol
Log daily doses, anxiety scores, mood, sleep quality, and cycle days with Shotlee to understand how Selank is working for your anxiety and wellbeing.
Track Selank Free